100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 2

Starting from August 26th, Women’s Equality Day in the United States—a day celebrating the 1920 law that granted U.S. women the right to vote—OncoDaily is thrilled to present the 2024 edition of “100 Influential Women in Oncology.” Each week, we’ll spotlight 10 extraordinary women leaders in oncology from around the globe, sharing their achievements and social media profiles for you to follow and be inspired by.

In 2023, we shared the stories of 100 influential women in oncology who are making a difference in cancer research, patient care, and advocacy. This year, we’re excited to continue this tradition, recognizing those who have made significant impacts in the field. While it’s impossible to include everyone deserving of recognition, we hope this list serves as an inspiration to many.

Below is the second part of our list of 100 Influential Women in Oncology to follow in 2024:

Yelena Janjigian is a Professor of Medicine at Weill Cornell Medical College and the Chief of Gastrointestinal Oncology at the Memorial Sloan Kettering Cancer Center in New York. She serves on the Steering Committee of the Giants of Cancer Care and is a member of the International Gastric Cancer Association Council. Dr. Janjigian is a recipient of the ASCO Conquer Cancer Foundation Career Development Award, Debbie’s Dream Foundation Medical Award, and Cycle for Survival Grant Award. She is on the Editorial Board of OncoDaily.
Follow Dr. Janjigian on X and LinkedIn.

Bente Mikkelsen is the Director of Noncommunicable Diseases in the Division of UHC/Communicable and Noncommunicable Diseases at the World Health Organization (WHO) Headquarters in Geneva, Switzerland. She was formerly the Director of the Division of Noncommunicable Diseases and Promoting Health through the Life-course at the WHO Regional Office for Europe and CEO of the Southern and Eastern Norway Regional Health Authority. Dr. Mikkelsen is trained as a Gynaecologist and Obstetrician and holds a Master’s degree in Health Administration and Management from the University of Oslo. Her current focus is on achieving the SDGs through the reduction of premature deaths from NCDs.
Follow Dr. Mikkelsen on X and LinkedIn.

Lynn Schuchter is the chief of the Division of Hematology-Oncology at the Abramson Cancer Center at the University of Pennsylvania, director of the Tara Miller Melanoma Center at the Abramson Cancer Center, and the Madlyn and Leonard Abramson Professor of Clinical Oncology at the Perelman School of Medicine at the University of Pennsylvania. Dr. Schuchter is a clinical investigator in the area of melanoma and has a strong commitment to mentorship. She served on the ASCO Board of Directors from 2009 to 2012 and is the 2023-2024 President of the American Society of Clinical Oncology (ASCO).
Follow Dr. Schuchter on X.

Susanne Wollaert is the CEO of the International Society of Paediatric Oncology (SIOP). She manages the day-to-day business and supports the board and members in successfully advancing their objectives through the ever-changing and expanding healthcare environment. With over 10 years of experience in the management of physician healthcare associations, Susanne has developed expertise in all the main aspects of running a professional society, and contributed significantly to the growth of the SIOP.
Follow Susanne Wollaert on LinkedIn.

Dean Crowe is the Founder and CEO of Rally Foundation for Childhood Cancer Research, a non-profit organization based in Atlanta that funds childhood cancer research through grassroots initiatives. By vision and leadership, Dean works to empower a nationwide group of volunteers, families, and friends who want to “do something” to help in the fight against childhood cancer. She also leads Rally’s national advocacy efforts. Dean has a background in commercial real estate sales and was a mortgage loan officer who got her start in fundraising by serving as the Campaign Director for Young Life’s national camp, SharpTop Cove.
Follow Dean Crowe on X and LinkedIn.

Noemi Reguart is a Consultant Oncologist at the Department of Medical Oncology in Hospital Clinic Barcelona and the Coordinator of the Thoracic Oncology Unit. She has been deeply involved in the design and patient recruitment for many personalized lung cancer trials. Dr. Reguart is a Clinical Professor at the University of Barcelona, deeply committed to under- and postgraduate teaching. She is a member of the Board of Directors of the Spanish Lung Cancer Group (SLCG) since 2007.
Follow Dr. Reguart on X and LinkedIn.

Rachna T. Shroff is the Associate Director of Clinical Investigations and co-leader of the Gastrointestinal Clinical Research Team at the University of Arizona Cancer Center (UACC). She is a professor with tenure in the Department of Medicine, chief of the Division of Hematology and Oncology, and Medical Director for the Oncology Service Line. She holds multiple positions nationally, including serving as the Hepatobiliary Subcommittee co-chair for the Southwest Oncology Group (SWOG) and as Chair for GI ASCO 2024. Most recently, she was elected to serve on the ASCO Nominating Committee.
Follow Dr. Shroff on X and LinkedIn.

Shikha Jain is a tenured associate professor of medicine in the Division of Hematology and Oncology at the University of Illinois Cancer Center in Chicago. She is the Director of Communication Strategies in Medicine and the Associate Director of Oncology Communication & Digital Innovation. Dr. Jain is a founder and Chair of the Women In Medicine Summit, and founder and President of the 501(c)(3) nonprofit Women in Medicine® She founded and co-chaired the inaugural Women In Medicine Symposium at Northwestern Memorial Hospital in Chicago in 2018 focused on promoting the advancement of women physicians at Northwestern. She is the co-founder of the Rush Center for the Advancement of Women in Health Care.
Follow Dr. Jain on X and LinkedIn.

Pat Garcia-Gonzalez is the Co-Founder and Chief Executive Officer of The Max Foundation, dedicated to improving the lives of cancer survivors worldwide. Under her leadership, the Foundation channels over 10 million doses of life-saving cancer treatment to patients in 72 low- and middle-income countries each year. Pat has been honored with the CEO Award from the Union for International Cancer Control; the distinguished Golden Tennis Shoe Award from United States Senator, Patty Murray; the first National Cancer Institute Global Cancer Medicine Humanitarian Award; and the inaugural Emerging Regions Support and Partnership (ERSAP) Prize.
Follow Pat Garcia-Gonzalez on X and LinkedIn. 

Jennifer S. Buell is the President and CEO of MiNK Therapeutics. She brings more than 25 years of biopharmaceutical experience, having previously served as President and COO at Agenus, where she transformed the company into a global, fully-integrated biotech firm. Before her time at Agenus, Dr. Buell held key positions at Bristol-Myers Squibb and the Harvard Clinical Research Institute (Baim), where she was deeply involved in the development and operational strategies of numerous clinical programs, both industry and government sponsored. Dr. Buell holds a Ph.D. from Tufts University.
Follow Dr. Buell on X and LinkedIn.

As we continue to highlight the outstanding contributions of these and other women leaders in oncology, we invite you to follow their journeys on social media and be part of their impact. Stay tuned for the next set of influential women in oncology next week!

Missed the previous highlights? Check out last year’s list and the first 10 in this year’s series for more inspiration.